advertisement
Wong JC 17
Showing records 1 to 17 | Display all abstracts from Wong JC104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Starr MR
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Wong JC
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Starr MR
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Wong JC
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Huang D
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Shiuey EJ; Razeghinejad R
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Wong JC; Wong JC
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Shukla AG; Shukla AG
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Patel LG
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Kolomeyer NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Ammar M
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Kolomeyer NN; Myers JS
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Hsu J; Sivalingam A
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Pro MJ
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Mehta S
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
104781 The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center
Lee D
Graefe's Archive for Clinical and Experimental Ophthalmology 2023; 261: 193-200
104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Ho AC; Kuriyan AE; Khan MA; Cohen MN; Xu D; Lee D; Moster MR; Yonekawa Y
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045
